Results 241 to 250 of about 50,787 (316)

Frequently Reported Blood Biomarkers in Sarcopenia Clinical Trials: A Systematic Review and Meta‐Analysis

open access: yesAging Cell, Volume 25, Issue 2, February 2026.
This systematic review and meta‐analysis identifies blood‐based biomarkers (BBMs) reported in sarcopenia trials, investigating the impact of sarcopenia interventions on BBMs concentrations. Significant heterogeneity was observed in sarcopenia outcomes. Interventions had a limited impact on BBMs, except for IGF‐1, which was significantly impacted by the
Emma Calluy   +10 more
wiley   +1 more source

Biomarkers in patients with clinical signs of mild cognitive impairment or mild Alzheimer's disease but without amyloid deposits on positron emission tomography: Results from Bio-Hermes Study participants. [PDF]

open access: yesAlzheimers Dement
Mohs RC   +11 more
europepmc   +1 more source

Serum levels of neurofilament light chain (NfL) and glial fibrillary acid protein (GFAP) in patients with asymptomatic and symptomatic carotid artery stenosis [PDF]

open access: gold
Robin Jansen   +20 more
openalex   +1 more source

A systematic review of brain health in adults with chronic pain

open access: yesAnaesthesia, Volume 81, Issue 2, Page 248-262, February 2026.
Summary Introduction Recent research has linked chronic pain with an increased risk of clinical dementia diagnosis. Yet structural and functional brain changes associated with chronic pain and their potential role in accelerating brain ageing have not been characterised comprehensively.
Angeline Lee   +22 more
wiley   +1 more source

Serum sTREM2 Levels and Disability Progression in Patients With Primary Progressive Multiple Sclerosis

open access: yesEuropean Journal of Neurology, Volume 33, Issue 2, February 2026.
ABSTRACT Background Triggering receptor expressed on myeloid cells 2 (TREM2) is a microglia surface receptor that aids in tissue repair and debris clearance. The soluble form, sTREM2, found in both blood and cerebrospinal fluid, is considered a biomarker for microglial activation.
Nicolás Fissolo   +26 more
wiley   +1 more source

Neurofilament Light Chain Concentration in the Prediction of Treatment Response in Multiple Sclerosis

open access: yesEuropean Journal of Neurology, Volume 33, Issue 2, February 2026.
This graphical abstract shows that serum NfL was evaluated alongside clinicodemographic variables that were reduced using principal component analysis (PCA). These components were then incorporated into a combined prognostic model. The addition of serum NfL did not result in any significant improvement in prognostic accuracy in the pooled cohort ...
Nahid Moradi   +18 more
wiley   +1 more source

Home - About - Disclaimer - Privacy